Single-dose Intramuscular-injection Toxicology Test of Water-soluble Carthami-flos and Cervi cornu parvum Pharmacopuncture in a Rat Model
1
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Objectives: The aim of the study is to investigate both the single-dose intramuscular injection toxicity and the approximate lethal dose of water-soluble Carthami-flos and Cervi cornu parvum pharmacopuncture (WCFC) in male and female Sprague-Dawley (SD) rats. Methods: The study was conducted at Biotoxtech Co. according to the Good Laboratory Practice (GLP) regulation and the toxicity test guidelines of the Ministry of Food and Drug Safety (MFDS) after approval of the Institutional Animal Care and Use Committee. Dosages for the control, high dose, middle dose and low dose groups were 0.5 mL/animal of saline and 0.5, 0.25 and 0.125 mL/animal of WCFC, respectively. WCFC was injected into the muscle of the left femoral region by using a disposable syringe (1 mL, 26 gauge). The general symptoms and mortality were observed 30 minutes, 1, 2, 4, and 6 hours after the first injection and then daily for 14 days after the injection. The body weights of the SD rats were measured on the day of the injection (before injection) and on the third, seventh, and fourteenth days after the injection. Serum biochemical and hematologic tests, necropsy examinations, and histopathologic examinations at the injection site were performed after the observation period. Results: No deaths, abnormal clinical symptoms, or significant weight changes were observed in either male or female SD rats in the control or the test (0.125, 0.25, and 0.5 mL/animal) groups during the observation period. No significant differences in hematology and serum biochemistry and no macroscopic abnormalities at necropsy were found. No abnormal reactions at injection sites were noted on the topical tolerance tests. Conclusion: The results of this single-dose toxicity study show that WCFC is safe, its lethal doses in male and female SD rats being estimated to be higher than 0.5 mL/animal.
Abstract
Objectives: The aim of the study is to investigate both the single-dose intramuscular injection toxicity and the approximate lethal dose of water-soluble Carthami-flos and Cervi cornu parvum pharmacopuncture (WCFC) in male and female Sprague-Dawley (SD) rats. Methods: The study was conducted at Biotoxtech Co. according to the Good Laboratory Practice (GLP) regulation and the toxicity test guidelines of the Ministry of Food and Drug Safety (MFDS) after approval of the Institutional Animal Care and Use Committee. Dosages for the control, high dose, middle dose and low dose groups were 0.5 mL/animal of saline and 0.5, 0.25 and 0.125 mL/animal of WCFC, respectively. WCFC was injected into the muscle of the left femoral region by using a disposable syringe (1 mL, 26 gauge). The general symptoms and mortality were observed 30 minutes, 1, 2, 4, and 6 hours after the first injection and then daily for 14 days after the injection. The body weights of the SD rats were measured on the day of the injection (before injection) and on the third, seventh, and fourteenth days after the injection. Serum biochemical and hematologic tests, necropsy examinations, and histopathologic examinations at the injection site were performed after the observation period. Results: No deaths, abnormal clinical symptoms, or significant weight changes were observed in either male or female SD rats in the control or the test (0.125, 0.25, and 0.5 mL/animal) groups during the observation period. No significant differences in hematology and serum biochemistry and no macroscopic abnormalities at necropsy were found. No abnormal reactions at injection sites were noted on the topical tolerance tests. Conclusion: The results of this single-dose toxicity study show that WCFC is safe, its lethal doses in male and female SD rats being estimated to be higher than 0.5 mL/animal.
참고문헌 (18)
- Korean Pharmacopuncture Institute, "Pharmacopuncturology: principles and clinical application, Chapter 7, Meridian field pharmacopuncture" (2012), Elsevier Korea LLC
- 정다정, "Single Intravenous-dose Toxicity of Water-soluble Carthami-flos Pharmacopuncture (WCF) in Rats", Journal of Pharmacopuncture, 17(3), pp.31~39 (2014), 대한약침학회[DOI]
- 박재연, "갱년기 여성의 경항통에 대한 홍화 약침 치료의 임상적 고찰", Journal of Pharmacopuncture, 14(4), pp.71~80 (2011), 대한약침학회
- 이건목, "頸椎椎間板 脫出症 患者의 紅花藥鍼治療에 대한 臨床的 考察", 대한침구의학회지, 23(3), pp.21~35 (2006), 대한침구의학회
- 신민근, "만성 해수에 대한 肺俞(BL13) 녹용약침 치험 6례", 대한침구의학회지, 30(5), pp.253~262 (2013), 대한침구의학회
- 김성옥, "녹용 약침이 국소 뇌허혈 모델 백서에서 방사형 미로과제 학습 및 뇌신경 보호에 미치는 영향", Korean Journal of Acupuncture, 22(4), pp.67~81 (2005), 경락경혈학회
- 권기록, "The clinical studies on the cased of side effect of CF Herbal Acupuncture", Journal of Pharmacopuncture, 4(2), pp.65~71 (2001), 대한약침학회[DOI]
- 이종영, "경락약침의 윤제(CF, JsD)에 의한 부작용 사례보고", Journal of Pharmacopuncture, 10(3), pp.137~142 (2007), 대한약침학회
- 김병우, "윤제약침(CF, JsD)이 생체 조직에 미치는 영향", Journal of Pharmacopuncture, 13(1), pp.87~92 (2010), 대한약침학회
- 이형걸, "Single Intramuscular-dose Toxicity of Water soluble Carthmi-Flos herbal acupuncture (WCF) in Sprague-Dawley Rats", Journal of Pharmacopuncture, 17(1), pp.27~34 (2014), 대한약침학회[DOI]
- Beijing Medical College, "Dictionary of traditional Chinese medicine", pp.193~213 (1984), The Commercial Press Ltd
- Han JH, "The pharmacology of Korean traditional medicine", pp.375~498 (2004), EuiSeongDang Publishing Co
- Jeong, Min-Su, "Effectiveness of herbal acupuncture of Carthami semen(Honghwa) vs its cotreatment with spiral taping for the treatment of acute low back pain : A randomized controlled trial", Journal of Pharmacopuncture, 5(2), pp.25~38 (2002), 대한약침학회[DOI]
- Kwak DU, "A regulatory effect of Cervi cornu parvum aqua-acupuncture on serum estradiol level after ovariectomy", The Acupuncture, 15(2), pp.29~41 (1998)
- 임사비나, "The Effects of Cervus elaphus Aquapuncture and Ginseng Radix Aquapuncture on the Growth of Animals", Journal of Pharmacopuncture, 3(2), pp.131~152 (2000), 대한약침학회[DOI]
- Abadjieva DK, "Effect of Cervi cornu aqua-acupuncture on lipid metabolism and osteoporosis in ovariectomized rats", J Korean Oriental Med, 17(2), pp.168~177 (1996)
- Kim HJ, "Analysis of physioactivities on HN yakchim", Korea Immuno-Yakchim Society, 1(1), pp.33~42 (2012)
- Seo SS, "Correction of nasolabial folds with HN yakchim and needle-embedding therapy and following up the case", Korea Immuno-Yakchim Society, 2(1), pp.57~64 (2013)
